'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

Clinical trial NCT04553926 · COMPLETED

Trial details

NCT number: NCT04553926
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Ovarian Cancer Breast Cancer Prostate Cancer Pancreatic Cancer

Start date: 2021-02-01
Primary completion: 2025-07-11
Enrollment: 661

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.